Pharmacological impact on sleep architecture and polysomnographic measures in Restless Legs Syndrome: A systematic review
Authors:
- 5 August 2025
- journal article
- review article
- Published by Elsevier in Sleep Medicine Reviews
- Vol. 83, 102147
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health (2787055)
This publication has 86 references indexed in Scilit:
- Evidence of Involvement of the Calcitonin Gene‐Related Peptide in Restless Legs SyndromeMovement Disorders, 2025
- Restless legs syndrome and cognitive function among adults: a systematic review and meta-analysisJournal of Neurology, 2022
- A Randomized, Placebo‐Controlled Crossover Study with Dipyridamole for Restless Legs SyndromeMovement Disorders, 2021
- Increased Blood Pressure Dipping in Restless Legs Syndrome With Rotigotine: A Randomized TrialMovement Disorders, 2020
- Defining the phenotype of restless legs syndrome/Willis–Ekbom disease (RLS/WED): a clinical and polysomnographic studyJournal of Neurology, 2016
- Dissociation of periodic leg movements from arousals in restless legs syndromeAnnals of Neurology, 2012
- Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndromeMovement Disorders, 2011
- Pramipexole versus ropinirole: Polysomnographic acute effects in restless legs syndromeMovement Disorders, 2011
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Long‐Term follow‐up on restless legs syndrome patients treated with opioidsMovement Disorders, 2001